Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?

Hyun Ho Choi

Division of Gastroenterology

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	668-669
Number of pages	2
Journal	Gut and Liver
Volume	17
Issue number	5
DOIs	https://doi.org/10.5009/gnl230338
State	Published - Sep 2023

Access to Document

10.5009/gnl230338

Other files and links

Link to publication in Scopus

Cite this

@article{9e293b8412ae446e9ee70b316a2a8edd,

title = "Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?",

author = "Choi, {Hyun Ho}",

year = "2023",

month = sep,

doi = "10.5009/gnl230338",

language = "English",

volume = "17",

pages = "668--669",

journal = "Gut and Liver",

issn = "1976-2283",

publisher = "Joe Bok Chung",

number = "5",

}

TY - JOUR

T1 - Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance?

AU - Choi, Hyun Ho

PY - 2023/9

Y1 - 2023/9

UR - http://www.scopus.com/inward/record.url?scp=85171338742&partnerID=8YFLogxK

U2 - 10.5009/gnl230338

DO - 10.5009/gnl230338

M3 - Editorial

C2 - 37712188

AN - SCOPUS:85171338742

SN - 1976-2283

VL - 17

SP - 668

EP - 669

JO - Gut and Liver

JF - Gut and Liver

IS - 5

ER -